^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PATHWAY antiHer2/neu (4B5) Rabbit Monoclonal Primary Antibody

    Company:
    Roche
    Type:
    FDA Approved
    Related tests:
    Evidence Level:
    Sensitive: A1 - Approval

    [HER-2 positive-HER2 Positive Breast Cancer-ado-trastuzumab emtansine]

    Source:
    FDA
    Test:

    INFORM HER2 Dual ISH DNA Probe Cocktail, PATHWAY antiHer2/neu (4B5) Rabbit Monoclonal Primary Antibody

    Excerpt:
    KADCYLA is a HER2-targeted antibody and microtubule inhibitor conjugate indicated, as a single agent, for...the treatment of patients with HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination.